Order Article Reprints

Rossi C, Lanuti P, Cicalini I, De Bellis D, Pierdomenico L, Del Boccio P, Zucchelli M, Natale L, Sinjari B, Catitti G, et al. BNT162b2 mRNA Vaccination Leads to Long-Term Protection from COVID-19 Disease. Vaccines. 2021; 9(10):1164. https://doi.org/10.3390/vaccines9101164

Rossi, Claudia, Paola Lanuti, Ilaria Cicalini, Domenico De Bellis, Laura Pierdomenico, Piero Del Boccio, Mirco Zucchelli, Luca Natale, Bruna Sinjari, Giulia Catitti, and et al. 2021. "BNT162b2 mRNA Vaccination Leads to Long-Term Protection from COVID-19 Disease" Vaccines 9, no. 10: 1164. https://doi.org/10.3390/vaccines9101164

Rossi, C., Lanuti, P., Cicalini, I., De Bellis, D., Pierdomenico, L., Del Boccio, P., Zucchelli, M., Natale, L., Sinjari, B., Catitti, G., Vespa, S., Simeone, P., Bologna, G., Bucci, I., Falasca, K., Vecchiet, J., Stuppia, L., De Laurenzi, V., & Pieragostino, D. (2021). BNT162b2 mRNA Vaccination Leads to Long-Term Protection from COVID-19 Disease. Vaccines, 9(10), 1164. https://doi.org/10.3390/vaccines9101164